InvestorsHub Logo
Followers 17
Posts 1224
Boards Moderated 1
Alias Born 06/30/2014

Re: None

Sunday, 10/04/2020 7:00:27 PM

Sunday, October 04, 2020 7:00:27 PM

Post# of 140474
Reply 117068 Geo, then we agree but not on the "what's it worth when the offer is made." I don't think MDT waits until this gets approved. I think other outside influences may create bigger problems than they are worth waiting for the BO done after FDA. Who's to say the MDT person on the Oversight Committee isn't on a conference call when TMDI asks about any loose ends, or discusses cadaver studies. MDT will know more well before FDA. Their close to a verbal contract, and wouldn't take much to get there and then Mc will have to disclose it b/c it's material. We'll know more, unfortunately in bits and pieces until spring '21. Unless, some unforeseen issue, or outside event causes a change in the timeline.

How can this buyout be less than several $B? My guess is 6. Which is based on value of IP, and revenue potential b/c of the design(s). MDT looked over the universe of possibilities, and saw no other design worthy. It's going to be many $B's b/c it's a 20 year design.

Yes, we have a long way to go. But, we're a lot further along than even 2 years ago.

Just curious, what's your opinion of FaceTrains estimates?

Good luck to all. Regards,BK